Ledger.Open graph →
SEC Form D · Amendment · filed February 22, 2010

Drais Pharmaceuticals Inc

Offering
Sold
$20.0M
Exemption
Industry
Biotechnology
Location
Bridgewater, NJ
Type

People & firms on this filing (4)

Donna Tempel · Bridgewater, NJExec · DirectorRobert Desjardins · Bridgewater, NJExec · DirectorArnold Oronsky · Bridgewater, NJExecJeff Bird · Bridgewater, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗